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Abstract: The effects of guanine nucleotides on binding 
of 8-cyclopentyl-1,3-[3H]dipropylxanthine <eH]DPCPX), a 
highly selective A1 adenosine receptor antagonist, have been 
investigated in rat brain membranes and solubilized A1 re-
ceptors. GTP, which induces uncoupling of receptors from 
guanine nucleotide binding proteins, increased binding of 
[ 3H]DPCPX in a concentration-dependent manner. The rank 
order of potency for different guanine nucleotides for in-
creasing eH]DPCPX bindingwas the same as for guanine 
nuc1eotide-induced inhibition of agonist binding. Therefore, 
a role for a guanine nucleotide binding protein, e.g., Gi, in 
the regulation of antagonist binding is suggested. This was 
confirmed by inactivation ofGi by N-ethylmaleimide (NEM) 
treatment of membranes, which resulted in an increase in 
[ 3H]DPCPX binding similar to that seen with addition of 
GTP. Kinetic and equilibrium binding studies showed that 
the GTP- or NEM-induced increase in antagonist binding 
A1 adenosine receptors are members of the family 
ofreceptors that couple to an effector systemvia a gua-
nine nucleotide binding protein (G protein). In the past, 
A1 receptors have been characterized by means ofbio-
chemical and pharmacological methods (for review, 
see Lohse et al., 1988). It is generally accepted that G 
protein-coupled receptors can occur in two different 
affinity states for agonists. These receptors are in a high-
affinity state when they are coupled to a G protein. 
GTP binding to the G protein induces dissociation of 
the receptor-G protein complex and shifts receptors 
to a low-affinity form (Gilman, 1987). GTP regulation 
of agonist binding has been shown for membrane-
bound and solubilized A1 adenosine receptors (Gavi~h 
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was not caused by an affinity change of A 1 receptors for 
[ 3H]DPCPX but by an increased Bmu value. Guanine nu-
cleotides had similar effects on membrane-bound and solu-
bilized receptors, with the effects in the solubilized system 
being more pronounced. In the absence of GTP, when rnost 
receptors are in a high-affinity state for agonists, only a few 
receptors are labeled by [3H]DPCPX. It is suggested that 
[ 3H]DPCPX binding is inhibited when receptors are coupled 
to Gj. Therefore, uncoupling of A1 receptors from Gi by gua-
nine nucleotides or by inactivation of Gi with NEM results 
in an increased antagonist binding. Key Words: Adenosine 
receptors-8 -Cyclopentyl-1,3-eH]dipropylxanthine-An-
tagenist binding-Guanine nucleotide effects. Klotz K.-N. 
et al. Guanine nucleotide etfects on 8-cyclopentyl-1 ,3-eH]-
dipropylxanthine binding to membrane-bound and solubi-
lized A1 adenosine receptors of rat brain. J. Neurochem. 54, 
1988-1994 (1990). 
et al., 1982; Goodman et al., 1982; Lohse et al., 1984a; 
Klotz et al., 1986). 
Conflicting results have been obtained for GTP ef-
fects on antagonist binding to adenosine receptors. In 
bovine and rat brain, no GTP modulation was detected 
(Goodman et al., 1982; Lohse et al., 1984a; Klotz et 
al., 1986), whereas other studies showed slightly in-
creased affinity in rat adipocytes (Ramkumar and 
Stiles, 1988) or increased Bmax values in rat hippocam-
pus and bovine brain (Yeung and Green, 1983; Stiles, 
1988) on GTP addition. In the past, the examination 
of GTP effects was hampered by the fact that only the 
weak antagonist radioligand 1 ,3-[3H]diethyl-8-phe-
nylxanthine ([3H]DPX) was available. Recently, 
DPCPX, 8-cyclopentyl-1,3-[3H]dipropylxanthine; [3H]DPX, l ,3-
[lH]diethyl-8-phenylxanthine; G protein, guanine nucleotide binding 
protein; Gi and Gu inhibitory and stimulatory guanine nucleotide 
binding protein, respectively; NEM, N-ethylmaleimide; [3H]PIA, R-
N6-[3H]phenylisopropyladenosine; (3H]XAC, (3H]xanthine amine 
congener. 
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[3H]xanthine amine congener ([3H]XAC) (Jacobson et 
al., 1986) with nanomolar affinity, but high nonspecific 
binding, becarne available and was used by the group 
of Stiles (Ramkumar and Stiles, 1988; Stiles, 1988). 
The introduction of 8-cyclopentyl-1 ,3-[3H]dipropyl-
xanthine ([3H]DPCPX) (Bruns et al., 1987; Lohse et 
al., 1987) with high selectivity and subnanomolar af-
finity for the A 1 receptor enabled a closer Iook at GTP 
modulation ofantagonist binding. We consistently ob-
served an increase in binding of [3H]DPCPX on GTP 
addition at both mernbrane-bound and solubilized re-
ceptors. Therefore, we studied GTP modulation of an-
tagonist binding in rnore detail and report now con-
ditions that show more pronounced GTP effects on 
antagonist binding. 
MATERIALSAND METHODS 
Materials 
R-N6-[3H]Phenylisopropyladenosine {PH]PIA) was pur-
chased from Du Pont-New England Nuclear (Dreieich, 
F.R.G.), and [3H]DPCPX was from Amersham Buchler 
(Braunschweig, F.R.G.). All nucleotides were obtained from 
Boehringer Mannheim (Mannheim, F.R.G.). 3-[3-(Chol-
amidopropyl)dimethylammonio]-1-propanesulfonatc 
(CHAPS) and polyethylenimine were from Sigma (Deisen-
hofen, F.R.G.). All otherchemicals were ofthe highest purity 
available. 
Preparation of membranes 
Membranes from whole rat brains were prepared as de-
scribed by Lohse et al. ( 1984b). Pretreatment of membranes 
with N-ethylmaleimide (NEM) before radioligand binding 
was done as described recently (Klotz et al., 1988). 
Solubilization of rat brain membranes 
The solubilization ofrat brain membranes was performed 
as described previously (Klotz et al., 1986) with some mod-
ifications. The initial washing step with EDTA-containing 
buffer was omitted, because results were not fundamentally 
different with EDT A-treated membranes (see Discussion). 
Membranes were suspended in ice-cold water containing 1% 
CHAPS at a protein concentration of 5 mg/ml and incubated 
for 15 min on ice. The extract was diluted with the respective 
incubation buffer to a CHAPS concentration of 0.4% and 
then centrifuged for 30 min at 100,000 g. The supernatant 
was used as the solubilized receptor preparation. 
Radioligand binding assay 
Radioligand binding was performed as reported previously 
(Lohse et al., 1987) with the following modifications. All 
binding experiments were done in 50 mM histidine butfer at 
pH 6 (free histidine base adjusted with. HCI), because the 
GTP effect on antagonist binding was more pronounced at 
pH values of <7. Experiments at pH 7.4 were done in 50 
mMTris-HCI. eH]DPCPX (or [3H]PIA) was incubated at a 
final concentration of 0.2 nM (or 1 nM) with 50 1-'g (or 100 
1-'8) of membrane protein (or solubilized receptors from the 
same amount of protein) in a total volume of 250 or 500 JJ.l 
in saturation experiments. Membranes were incubated with 
either radioligand for 2 h at 25 °C and then filtered over 
Whatman GF/B glass fiber filters. Solubilized receptors were 
incubated with [3H]DPCPX at l2°C, and the binding reaction 
was stopped after 2 h by filtration over polyethylenimine-
treated filters (Bruns et al., 1983). eHJPIA was equilibrated 
for 20 h, because membranes were not treated with EDT A. 
The endogenaus Mg2+ Ievels are sufficient to slow the asso-
ciation rate, as has been shown earlier (Klotz et al., 1986). 
Adenosine deaminase (ADA) was present at a concentration 
of0.2 U/ml. This concentration is supposed tobe high enough 
to remove endogenaus adenosine, because [3H]DPCPX 
bindingwas maximally enhanced at a concentration of ADA 
as low as 0.003 U/ml. Nonspecific bindingwas determined 
in the presence of 10 J.LM R-PIA or 1 rnM theophylline for 
[ 3H]DPCPX and eH]PIA binding, respectively. Radioligand 
bound refers to specific binding or as indicated. 
Data analysis 
Saturation data were analyzed with the nonlinear curve-
fitting program SCTFIT (De Lean et al., 1982a). Kinetic data 
were fitted to monoexponential equations (Lohse et al., 
1984a), and concentration-response curves were analyzed 
by nonlinear regression as described by Lohse et al. ( 1986). 
RESULTS 
GTP consistently induced a small increase in binding 
ofthe high-affinity antagonist [3H]DPCPX in rat brain 
membranes. This effect was dependent on the pH of 
the incubation buffer and was more pronounced at pH 
values of <7. At pH 6, a 40-80% increase in 
[ 3H]DPCPX binding was observed. Figure l shows the 
concentration dependence of the effect for different 
guanine nucleotides. The EC50 of 3 j.tM for the GTP-
induced Stimulation of[3H]DPCPX binding resembled 
the IC50 for inhibition of binding of the agonist 
[3H]PIA, which is --9 p.M at pH 6 (data not shown). 
NEM pretreatment of membranes, which inactivates 
the inhibitory G protein (Gi), induced a concentration-
dependent increase in [3H]DPCPX binding (Fig. 2). 
The NEM-induced increase in antagonist binding fol-
lowed the same concentration dependence as the NEM-
induced decrease in binding of the agonist [3H]PIA. 
The association time courses in Fig. 3 show that both 
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FIG. 1. Concentration dependence of the increase in [3H]DPCPX 
binding for different guanine nucleotides. Specific binding of 
[ 3H]DPCPX to membranes ls shown in the presence of lncreasing 
concentrations of guanosine-5'-0{3-thio)triphosphate (+}. GTP (e}, 
GDP (•). and GMP (0). 
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FIG. 2. Concentration dependence of NEM pretreatment of rat 
brain membranes on [3H]DPCPX and [3H]PIA binding. Membranes 
were treated with lncreasing concentrations of NEM; then, radio-
ligand bindingwas measured as described in Materialsand Meth-
ods. Shown are the percent increase in [3H]DPCPX binding (e) 
and the percent decrease in [3H]PIA binding (0). 
GTP and NEM pretreatment increased equilibrium 
binding of [3H]DPCPX, which is rcached at all con-
ditions after ,_,I h. GTP addition to control mem-
branes after binding equilibrium was attained enhanced 
[ 3H]DPCPX binding to the Ievel of the GTP curve. 
GTP had no further effect in NEM-pretreated mem-
branes. 
To clarify whether the increased antagonist binding 
is caused by a change in kinetic parameters and a re-
sulting affinity change or not, rate constants for asso-
ciation and dissociation were determined. The exper-
iments shown in Fig. 4 suggest that no change in kinetic 
parameters occurred. The presence of GTP or pre-
treatment with NEM had only minor effects on rate 
constants; thus, the K0 values calculated from these 
data are in close agreement (Table 1 ). This indicates 
that GTP atfected [3H]DPCPX binding with no change 
of the affinity of A1 receptors for this antagonist. 
To confirm further the Iack of an etfect of GTP on 
affinity of [3H]DPCPX for At receptors, we performed 
equilibrium binding studies. The saturation experi-
ments shown in Fig. 5 clearly demonstrate that GTP 
increased eHJDPCPX binding by increasing the Bmax. 
value, with almost no change in the K0 value. In ad-
dition, it is shown that inactivation ofGi by NEM pre-
treatment resulted in a similar increase of the Bmax. 
value, again with only a minor effect on the K0 . Kinetic 
and equilibrium binding data are summarized in Table 
1. In contrast to this observation in saturation exper-
iments in the absence of ADA, a change in the K0 
value was observed on addition ofGTP or ADA (data 
not shown). 
The reversibility ofthe GTP etfect is shown in Table 
2. Membranes were first incubated with GTP, which 
increased binding of [3H]DPCPX. Washing the mem-
branes with butfer reduced binding to the Ievel of con-
trol membranes. Addition of GTP to washed mem-
branes enhanced binding to similar Ievels as before the 
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washing procedure. The presence or absence of ADA 
during the pretreatment had no effect on the results. 
It has been shown that solubilized At adenosine re-
ceptors remain coupled to a G protein, because agonist 
binding is GTP modulated, as is binding to membrane-
bound receptors (Gavish et al., 1982; Klotzet al., 1986). 
Similar experiments were, therefore, performed with 
solubilized receptors. Again, binding in the presence 
ofGTP is highest at pH 6, but in cantrast to membrane-
bound receptors, a marked GTP effect was also ob-
served in the physiological pH range. 
Saturation of solubilized At receptors with 
[ 3H]DPCPX demonstrated that GTP increased the 
Bmax. value by almost fivefold, whereas the K 0 value 
was not substantially affected (Fig. 6). In accordance 
with the results for membrane-bound receptors, the 
GTP effect is not caused by a change in the affinity for 
the antagonist. The reversibility ofthe GTP effect was 
also observed when control and GTP-treated mem-
branes were washed and then solubilized (Table 2). 
The magnitude of the GTP-induced increase of 
[3H]DPCPX binding to solubilized receptors seemed 
to be highly dependent on the solubilization procedure. 
Centrifugation of the membrane extract at a CHAPS 
concentration of 1% (see Materials and Methods) re-
sulted in a twofold increase, whereas about a fourfold 
increase was measured after centrifugation at 0.2-0.6% 
CHAPS (data not shown). The effect of the protein 
concentration during solubilization was even more 
pronounced. Control binding of [3H]DPCPX in the 
absence ofGTP decreased with increasing protein con-
centration (Fig. 7). In the presence of GTP, binding 
was almost constant at protein concentrations of 1-5 
mgjml. This resulted in a relative GTP-induced in-
crease by a factor of up to about eightfold. The decrease 
in binding at l 0 mg/ml might be caused by a reduced 
solubilization yield. The prcsence of adenosine or ADA 
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FIG. 3. Effect of GTP and NEM pretreatment of membranes on 
[ 3H]DPCPX binding. Membranes were incubated in the absence 
(e) or presenoe of 100 ~ GTP (•) or after NEM pretreatment of 
membranes (6). The arrow indicates GTP addition to control (0) 
or NEM-pretreated (f:.) membranes after binding equilibrium was 
attained. 
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FIG. 4. Association (left) and dissociation (right) time courses for [3H]DPCPX binding. Specific binding is shown from a representative 
experiment as a percentage of the respective equilibrium binding. Rate constants for association (k,) are 0.212, 0.188, and 0.154 nmol-1 
min-1 in the absence (e) or presence of 100 JLM GTP (•) or after NEM pretreatment of membranes (+), respectively. Dissociation was 
induced by theophylline addition to a final concentration of 1 mM. The rate constants for dissociation (k_,) are 0.0502, 0.0559, and 0.0573 
min-1 in the absence or presence of GTP or after NEM pretreatment, respectivety. 
during solubilization did not influence the GTP effect 
determined in the solubilized preparation. Moreover, 
the same [3H]DPCPX binding was measured whether 
GTP was present already during solubilization or only 
during binding. 
DISCUSSION 
The effects of guanine nucleotides on antagonist 
binding to A1 adenosine receptors are still contested. 
Some guanine nucleotide effects might be overlooked 
by the use of the weak antagonist [3H]DPX. 
[ 3H]DPCPX is a radiolabeled antagonist with high af-
finity and selectivity for the A1 receptor and a high 
specific radioactivity and therefore proved to be a useful 
tool for investigating guanine nucleotide effects on an-
tagonist binding. In addition, we took advantage of 
incubation conditions that dramatically increased the 
guanine nucleotide effect on binding of [3H]DPCPX, 
in particular at solubilized receptors. Incubation at pH 
6 in histidine buffer was determined to be a very useful 
condition for this purpose. 
TADLE 1. Camparisan afkinetic and equi/ibrium datafar 
rHJDPCPX binding ta A 1 adenasine receptars 
fram rat brain membranes 
Equilibrium 
Kinetic BmaK 
Membrane Ko(nM) Ko(nM) (fmoljmg) 
Control 0.24 0.45 330 
GTP 0.30 0.31 620 
NEM-treated 0.37 0.27 580 
Kinetic Ko values were calculated from the rate constants shown 
in Fig. 4, and equilibrium data are from Fig. 5. 
The guanine nucleotide-induced increase in 
[ 3H]DPCPX binding and the inhibition of binding of 
the agonist eH]PIA had a similar rank order of po-
tency, an observation suggesting a rote of Gi in both 
processes. This suggestion was further supported by 
inactivation of Gi by NEM pretreatment of mem-
branes, which induced an identical increase in binding 
as the presence of GTP with the same concentration 
dcpendence as the NEM-induced inactivation of ago-
nist binding. Binding data from kinetic and equilibrium 
experiments showed that enhanced binding of 
[3H]DPCPX cannot be attributed to a change in affinity 
of A 1 receptors for this antagonist. Saturation analysis 
showed an increased Bmax. value on GTP addition. 
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FIG. s. Saturation of [3H]DPCPX blndlng to rat braln membranes. 
Membranes were incubated in the absence (e) or presence of 100 
,JA GTP <•> or after NEM pretreatment of membranes (+) with 
increasing concentrations of [3H]DPCPX. Specific binding is shown 
from a representative experiment. Nonlinear curve fitting gave K0 
and Bffl81< values of 0.45 and 330, 0.31 and 620, and 0.27 nM and 
580 fmolfmg, respectively. 
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TADLE 2. Reversibility of the GTP-induced increase 
of[1H]DPCPX binding 
Mem branes, control 
Membranes, 100 p.M GTP 
Solubilized, control 
Solubilized, I 00 p,M GTP 
First 
incubation Washed 
291 ± 29 
405 ± 49° 
281 ± 31 
295 ± 35 
121 
176 
Washed 
+GTP 
364 ± 51° 
377 ± 55° 
513 
489 
Membranes were first incubated in the absence or presence of 100 
p.M GTP and then washed three times with butfer. After the washing 
step, a portion ofthe membranes was solubilized. [3H]DPCPX binding 
was measured with and without GTP after the first incubation and 
after the washing procedure. ADA was present throughout the entire 
procedure. For membranes, data (in fmol/mg) are mean ± SEM 
values from five independent experiments; for solubilized receptors, 
data are shown from a representative experiment. 
a p < 0.05 versus the respective control. 
The Iack of an effect on the apparent affinity ruled 
out the possibility that the GTP-induced increase was 
a eonsequenee of the presence ofendogenaus adeno-
sine, supposing a eompetitive interaction between li-
gand and reeeptor. Dissociation ofendogenaus aden-
osine caused by a GTP-induced shift of high-affinity 
binding sites to the low-affinity state would not ehange 
the Bmax value but would inerease the apparent affinity 
of the receptors for (3H]DPCPX. An affinity ehange 
was observed in saturation experiments in the absence 
of ADA on addition of GTP or ADA. This demon-
strates that A1 receptors in rat brain membranes show 
the attribute of a competitive system. The possibility 
that removal ofendogenaus adenosine may be the rea-
son for the GTP-induced increase of antagonist binding 
in this study could further be ruled out by showing 
reversibility of the GTP effeet. 
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FIG. 6. Saturation of [3H]DPCPX binding to solubilized receptors. 
Solubilized receptors were incubated in the absence (0) or presence 
of 1 00 pM GTP (e) with increasing concentrations of [3H]DPCPX. 
Specific binding is shown from a representative experiment. Non-
linear curve fitting gave K0 and Bma:JC values of 0.29 and 120, and 
0.21 nM and 580 fmol/mg, respectively. 
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FIG. 7. Dependance of [3H]DPCPX and [3H]PIA binding on protein 
concentration during solubilization. Radioligand binding is shown 
in the absence ( stipplad columns) and presence of 100 pM GTP 
(open columns). 
EDT A pretreatment of membranes was omitted in 
this study, because it did not qualitatively change re-
sults. It slightly diminished the GTP effect, because it 
induced a small increase of [3H]DPCPX binding by 
itself. Divalent eations like Mg2+ or Ca2+ have the op-
posite effects on receptor-G protein coupling compared 
with GTP. It is conclusive, therefore, that EDTA pre-
treatment and GTP have similar effects on G protein-
dependent events. 
In several receptor systems, e.g., dopamine (De Lean 
et al., 1982b) and musearlnie (Burgisser et al., 1982) 
receptors, it has been shown that antagonists bind to 
two different affinity states in the absenee of GTP. In 
these models, agonist and antagonist affinities were re-
eiprocally regulated by GTP. In contrast, at A1 aden-
osine receptors, only one affi.nity state for antagonists 
could be deteeted (Yeung and Green, 1983; Lohse et 
al., 1984a, 1987; Klotz et al., 1986; Ramkumar and 
Stiles, 1988). This seerns to be a fundamental difference 
to the above receptor systems. 
Several studies with A 1 receptors done in brain re-
ported no effeet of guanine nucleotides on antagonist 
binding (Gavish et al., 1982; Goodman et al., 1982; 
Lohse et al., 1984a; Klotzet al., 1986) or an enhaneed 
Bmax. value (Yeung and Green, 1983), whereas Ramku-
mar and Stiles ( 1988) reported a small effect of guanine 
nucleotides on affinity of the antagonist [3H]XAC in 
adipocyte membranes with no change in the Bmax. value. 
The increased affinity is attributed to an enhanced as-
sociation rate, whereas the dissociation rate is not af-
fected. The proposal that bound radioligand stabilizes 
the receptor in a guanine nucleotide-insensitive state 
GUANINE NUCLEOTIDE EFFECTS ON [ 3H]DPCPX BINDING 1993 
and thus the dissociation rate is not modulated by gua-
nine nucleotides could not be confirrned in our model. 
At both membrane-bound and solubilized receptors, 
GTP addition after binding equilibrium was attained 
in the absence of GTP increased [3H]DPCPX binding 
to the Ievel of the GTP curve (Fig. 3). It is not clear 
whether these represent true tissuc differences. 
A GTP-induced increase in antagonist bindingwas 
also seen at solubilized receptors and exhibited char-
acteristics similar to those at membrane-bound recep-
tors. Because G proteins seem tobe involved in the 
modulation of antagonist binding, this result was ex-
pected, because solubilized· A1 receptors still interact 
with a G protein (Gavish et al., 1982; Klotzet al., 1986). 
It is assumed that GTP binding to G proteins induces 
dissociation ofreceptor-G protein complexes and shifts 
receptors to a low-affinity state for agonists. Thus, 
eHJPIA binding to solubilized receptors is abolished 
in the presence of GTP (Klotz et al., 1986). 
[ 3H]DPCPX binding, an the other band, is low under 
conditions when receptors are preferentially in the high-
affi.nity state for agonists. The striking similarity be-
twcen [3H]DPCPX binding in the presence of GTP 
and binding of the agonist [3H]PIA in the absence of 
GTP lends support to the idea that [3H]DPCPX Iabels 
A1 receptors that are uncoupled from a G protein. 
Competition of agonists for [3H]DPCPX binding, 
however, clearly showed that this radioligand Iabels 
both G protein-coupled and -uncoupled receptors 
(Lohse et al., 1987). This discrepancy may be explained 
by coupfing of A1 receptors to different G proteins 
(Munshi and Linden, 1989). Thus, antagonists may 
bind to, e.g., RGi but not RG0 (or vice versa), whereas 
agonists bind to both coupled complexes. 
The high variability of the GTP effect in the solu-
bilized system could be attributed to slightly different 
solubilization protocols. In particular, the protein con-
centration during solubilization greatly influences the 
extent of the GTP-induced increase of [3H]DPCPX 
binding. The decreased binding with increasing protein 
concentration can be explained by increasing amounts 
of receptors coupled to Gi. Uncoupling these complexes 
by GTP addition or inactivation of Gi by NEM pre-
treatment of membranes thus induces an increase in 
antagonist binding. This idea corresponds to findings 
from reconstitution experiments with ß-adrenergic re-
ceptors and stimulatory G protein (G5) into phospho-
lipid vesicles (Cerione et al., 1984). These authors found 
increasing GTPase activity of Gs, even in tbe absence 
of an agonist, when reconstitution was perforrned with 
increasing concentrations of Gs and ß-adrenergic re-
ceptors. This was attributed to an increasing portion 
of receptor-Gs complexes. 
Our present data suggest a role for a G protein in 
the modulation of antagonist binding at A1 receptors. 
The finding that the extent of guanine nucleotide-
induced increase in binding of the antagonist 
· [ 3H]DPCPX is dependent on incubation conditions at 
both membrane-bound and solubilized receptors 
probably reflects different amounts of A1 receptors 
coupled to G proteins. In particular, with solubilized 
receptors we were able to increase dramatically the ex-
tent of the GTP-induced increase of [3H]DPCPX 
binding by changing solubilization conditions, whicb 
might influence protein interactions. GTP effects on 
antagonist binding reported previously were relatively 
small; thus, clear-cut conclusions were hard to draw. 
With the use of the high-affinity antagonist [3H]-
DPCPX and conditions demonstrating about an eight-
fold increase in [3H]DPCPX binding by GTP in our 
present study, we overcame these problems and clearly 
showed that no affi.nity change for this antagonist is 
induced by guanine nucleotides. It is not clear, how-
ever, whether the mechanism of GTP modulation of 
binding is the same for agonists and antagonists. 
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